Biotech Target N V - 18 May 2022 Form 4 Insider Report for Radius Health, Inc. (RDUS)

Role: 10%+ Owner
Signature: /s/Ivo Betschart
Issuer symbol: RDUS
Transactions as of: 18 May 2022
Transactions value $: $2,661,002
Form type: 4
Date filed: 20 May 2022, 11:35
Previous filing: 18 May 2022
Next filing: 30 Aug 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RDUS	Common Stock	Purchase	$2.66M	+478K	+5.79%	$5.57	8.73M	18 May 2022	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

Biotech Target N.V. is a wholly-owned subsidiary of BB Biotech AG. Accordingly, BB Biotech AG may be deemed to be the indirect beneficial owner of the securities of Radius Health, Inc. held directly or indirectly by Biotech Target N.V. This Form 4 is filed jointly by BB Biotech AG and Biotech Target N.V.